Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.36 |
| ▸ | HRH1 | P35367 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3201663 | 0.85 | SLC6A4 (0.32) | SLC6A2SLC6A4SLC6A3HRH1AOC3 | |
| SCHEMBL3859734 | 0.84 | HTR2A (0.36) | SLC6A2SLC6A4SLC6A3HTR2AHRH1 | |
| SCHEMBL3208441 | 0.82 | SLC6A2 (0.34) | SLC6A2SLC6A4SLC6A3AOC3 | |
| SCHEMBL3200652 | 0.80 | KDM4E (0.36) | MEN1MAPTCYP2C9KMT2ASLC6A2 | |
| SCHEMBL3202567 | 0.78 | MEN1 (0.35) | MEN1MAPTKMT2ATDP1 | |
| SCHEMBL3203622 | 0.77 | MEN1 (0.41) | MEN1MAPTCYP2C9KMT2AAOC3 | |
| Hydrochloric Acid SCHEMBL3209498 | 0.75 | CHRM2 (0.30) | HRH1 | |
| SCHEMBL3203225 | 0.75 | SLC6A4 (0.39) | SLC6A2SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL3263847 | 0.75 | — | — | |
| SCHEMBL3204900 | 0.74 | CACNA1F (0.30) | SLC6A3HRH1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1817837-B | Carbonyl compound and method for preparing the same | SUMITOMO CHEMICAL CO | 2010-06-16 | — | — | CN | disclosed |
| US-7732643-B2 | Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-08 | — | — | US | disclosed |
| US-7671226-B2 | Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-02 | — | — | US | disclosed |
| US-20100048933-A1 | TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME | HANAOKA HIDENORI | 2010-02-25 | — | — | US | disclosed |
| US-20090054607-A1 | Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same | HANAOKA HIDENORI | 2009-02-26 | — | — | US | disclosed |
| US-7439379-B2 | Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same | SUMITOMO CHEMICAL CO., LTD. (JP) | 2008-10-21 | — | — | US | disclosed |
| CN-100357303-C | Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer using the same | SUMITOMO CHEMICAL CO (JP) | 2007-12-26 | — | — | CN | disclosed |
| CN-1817837-A | Substituted cyclopentadiene and method for producing the same | SUMITOMO CHEMICAL CO (JP) | 2006-08-16 | — | — | CN | disclosed |
| CN-1578783-A | Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer using the same | SUMITOMO CHEMICAL CO (JP) | 2005-02-09 | — | — | CN | disclosed |
| US-20040242410-A1 | Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054607-A1 | Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same | C1R, C1S, AP1M1 | MEN1 1101/4885MAPT 2641/4885CYP2C9 1113/4885 |
| US-20100048933-A1 | TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME | C1R, C1S, AP1M1 | MEN1 1101/4885MAPT 2641/4885CYP2C9 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.